• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018
CONCLUSION: Nationally representative data show increasing impact of the vaccination program and herd protection. Vaccine effectiveness estimates will be increasingly affected by herd effects.PRIMARY FUNDING SOURCE: Centers for Disease Control and Prevention.PMID:35576590 | DOI:10.7326/M21-3798
Source: Annals of Internal Medicine - May 16, 2022 Category: Internal Medicine Authors: Hannah G Rosenblum Rayleen M Lewis Julia W Gargano Troy D Querec Elizabeth R Unger Lauri E Markowitz Source Type: research

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018
MMWR Morb Mortal Wkly Rep. 2021 Mar 26;70(12):415-420. doi: 10.15585/mmwr.mm7012a2.ABSTRACTHuman papillomavirus (HPV) is the most common sexually transmitted infection in the United States (1). Although most infections resolve without clinical sequalae, persistent HPV infection can cause cervical, other anogenital, and oropharyngeal cancers and anogenital warts. HPV vaccination has been recommended in the United States at age 11-12 years since 2006 for females and since 2011 for males. Catch-up vaccination is recommended through age 26 years.* A quadrivalent vaccine (4vHPV) targeting types 6, 11, 16, and 18 was mainly used...
Source: MMWR Morb Mortal Wkl... - March 25, 2021 Category: Epidemiology Authors: Hannah G Rosenblum Rayleen M Lewis Julia W Gargano Troy D Querec Elizabeth R Unger Lauri E Markowitz Source Type: research